Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 10/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 10/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 5/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | SSTR1 | P30872 | 1/20 | 0.37 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.37 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL6405588 | 1.00 | SLC6A2 (0.41) | SLC6A2SLC6A4SLC6A3CES1KMT2A | |
| SCHEMBL8759876 | 0.91 | KMT2A (0.42) | SLC6A2SLC6A4SLC6A3KMT2A | |
| SCHEMBL6397894 | 0.91 | KMT2A (0.42) | SLC6A2SLC6A4SLC6A3KMT2A | |
| Trifluoroacetic Acid SCHEMBL21640637 | 0.88 | CES1 (0.42) | SLC6A2SLC6A4SLC6A3CES1CYP3A4 | |
| SCHEMBL27838683 | 0.78 | CHRNB2 (0.46) | SLC6A2SLC6A4SLC6A3CES1 | |
| SCHEMBL12021655 | 0.76 | CHRNB2 (0.47) | KMT2A | |
| Trifluoroacetic Acid SCHEMBL6879701 | 0.72 | KDM1A (0.41) | SLC6A2SLC6A4SLC6A3 | |
| Trifluoroacetic Acid SCHEMBL6875842 | 0.72 | KDM1A (0.41) | SLC6A2SLC6A4SLC6A3 | |
| Trifluoroacetic Acid SCHEMBL9687612 | 0.71 | CHEK1 (0.40) | SLC6A2SLC6A4SLC6A3CES1KMT2A | |
| Trifluoroacetic Acid SCHEMBL8758752 | 0.70 | CES1 (0.31) | CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050004092-A1 | Penem derivatives and antimicrobial agent containing the same | DAIICHI SUNTORY PHARMA CO., LTD. (JP) | 2005-01-06 | — | — | US | disclosed |
| EP-0757051-B1 | PENEM DERIVATIVES AND ANTIMICROBIAL AGENT CONTAINING THE SAME | DAIICHI SUNTORY PHARMA CO LTD (JP) | 2003-10-29 | — | — | EP | disclosed |
| EP-0757051-A1 | PENEM DERIVATIVES AND ANTIMICROBIAL AGENT CONTAINING THE SAME | SUNTORY LIMITED (JP) | 1997-02-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050004092-A1 | Penem derivatives and antimicrobial agent containing the same | MRPL21, MRPS2, MRPS28 | SLC6A2 3194/4885SLC6A4 3085/4885SLC6A3 4010/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.